Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Mayo Clinic
Washington University School of Medicine
Henry Ford Health System
Roswell Park Cancer Institute
Vanderbilt-Ingram Cancer Center
Abramson Cancer Center at Penn Medicine
St. Jude Children's Research Hospital
University of Washington
Washington University School of Medicine
Capital Medical University
Hvidovre University Hospital
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
University of Rochester